Max Lugavere: First Alzheimer’s Creatine Trial Shows Shocking Results! | TUH #178
About this video
Recorded at the White House, Brecka talks with author Max Lugavere about a first small clinical trial of creatine in Alzheimer’s patients, which Lugavere describes as promising but preliminary. Lugavere, whose mother had a neurodegenerative condition, also criticises what he calls fraud and gatekeeping in Alzheimer’s and nutrition research, and both argue lifestyle basics deserve more attention.
Key takeaways
- Lugavere states the creatine Alzheimer’s trial was small and single-arm with no placebo group, so results are preliminary
- He claims creatine has evidence for cognitive support beyond its bodybuilding reputation
- Lugavere argues the Alzheimer’s field has been affected by fraud and narrow research narratives
- Both speakers argue people have more control over health destiny through basic habits than they often assume
Episode details: published June 26, 2025 · 104.7K views · 15:58 long. Summary written by Self Growth Videos from the episode itself. Gary Brecka is a commercial health figure, not a physician. The claims described are Brecka’s or his guests’, presented for education — not medical advice and not endorsed by Self Growth Videos. Consult a qualified professional before changing your own health practices.
← Previous: The Ultimate Detox Challenge Day 3 · Next: Every tooth is an organ. →
All Gary Brecka videos · Gary Brecka profile · The Ultimate Human (official site)
You Might Also Enjoy

The Alzheimer's Drug With a 25% Brain Bleed Risk - Dr. David Perlmutter | TUH #306
Explore →
Omega-3 and Brain Health + What the Research Shows | TUH #266
Explore →
Why Creatine Is a Must for Women Over 40 | Gary Brecka
Explore →
Max Lugavere: The 16 Year Alzheimer's Research Scandal Exposed | TUH #101
Explore →
You Won't Believe How Hydration Impacts Your Brain Power | TUH #080
Explore →